Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

01.06.2017 | original article

Comparison of rapid hybridization-based pathogen identification and resistance evaluation in sepsis using the Verigene® device paired with “good old culture”

verfasst von: Michael Berktold, Wolfgang Mutschlechner, Dorothea Orth-Höller

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2017

Einloggen, um Zugang zu erhalten

Summary

Rapid microbial diagnostics is important for septicemic patients. The current gold standard is blood culture with consecutive pathogen identification and antimicrobial susceptibility testing. However, these culture-based methods need at least 48 h.
The aim of this study was to compare Verigene® (Nanosphere, Northbrook, IL, USA), a rapid hybridization-based method, with conventional culture-based methods for detection of pathogens and resistance markers from positive blood cultures of septic patients.
In 85 of 100 tested blood culture samples (85 %), pathogen identification as well as resistance profile were identical in Verigene and conventional culture. In 4 %, discordant results were observed. In 9 %, conventional culture revealed a pathogen ID or resistance phenotype not included in the Verigene panel. In 2 % no Verigene result was available.
In conclusion, Verigene offers the availability of fast and reliable pathogen identification and resistance profile determination, which may result in an earlier start of adequate antimicrobial treatment.
Vorheriger Artikel SeptiFast versus blood culture in clinical routine – A report on 3 years experience
Nächster Artikel Malignant mixed müllerian tumor mimicking cervical carcinoma
Literatur
1.
Loonen AJM, Wolffs PFG, Bruggeman CA, van den Brule AJC. Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis. 2014;33(10):1687–702.CrossRefPubMed
2.
Klouche M, Schröder U. Rapid methods for diagnosis of bloodstream infections. Clin Chem Lab Med. 2008;46(7):888–908.PubMed
3.
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1 2013. http://​www.​eucast.​org.
4.
Kirkwood BR. Essential medical statistics. 1st edn. Oxford: Blackwell Science; 1988. pp. 76–86.
5.
Martin GS, Maninno DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 to 2000. N Engl J Med. 2003;348(16):1546–54.CrossRefPubMed
6.
Soogard M, Norgaard M, Dethlefsen C, Schonheyder HC. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52(1):61–9.CrossRef
7.
Skogberg K, Lyytikainen O, Ollgren J, Nuorti JP, Ruutu P. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect. 2012;18(6):E170–6.CrossRefPubMed
8.
Wilson J, Elgohari S, Livermoore DM, et al. Trends among pathogens reported as causing bacteraemia in England. Clin Microbiol Infect. 2011;17(3):451–8.CrossRefPubMed
9.
Moerer O, Quintel M. Sepsis in adult patients – definitions, epidemiology and economic aspects. Internist. 2009;50(7):788, 790–794,796–798.CrossRefPubMed
10.
Stiermaier T, Herkner H. Tobudic S et al Incidence and long-term outcome of sepsis on general wards and in an ICU at the General Hospital of Vienna: an observational cohort study. Wien Klin Wochenschr. 2013;125(11–12):302–8.CrossRefPubMed
11.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.CrossRefPubMed
12.
Micek ST, Welch EC. Khan J et al Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother. 2010;54(5):1742–8.CrossRefPubMedPubMedCentral
13.
Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005;51(4):171–6.CrossRefPubMed
14.
Bhatti MM, Boonlayangoor S, Beavis KG, Tesic V. Evaluation of FilmArray and Verigene systems for rapid identification of positive blood cultures. J Clin Microbiol. 2014;52(9):3433–6.CrossRefPubMedPubMedCentral
15.
Dodémont M, De Mendonça R, Nonhoff C, Roisin S, Denis O. Performance of the Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol. 2014;52(8):3085–7.CrossRefPubMedPubMedCentral
16.
Dodémont M, De Mendonça R, Nonhoff C, Roisin S, Denis O. Evaluation of Verigene Gram-positive blood culture assay performance for bacteremic patients. Eur J Clin Microbiol Infect Dis. 2015;34(3):473–7.CrossRefPubMed
17.
Grif K, Fille M. Würzner R et al Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr. 2012;124(7–8):266–70.CrossRefPubMed
18.
Burdino E, Ruggiero T, Allice T, et al. Combination of conventional blood culture and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogens. Diagn Microbiol Infect Dis. 2014;79(3):3085–7.CrossRef
19.
Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23(4):317–22.CrossRefPubMed
20.
Ledeboer AL, Lopansri BK, Dhiman N, et al. Identification of gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the verigene gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol. 2015;53(8):2460–72.CrossRefPubMedPubMedCentral
21.
Tojo M, Fujita T, Ainoda Y, et al. Evaluation of an automated rapid diagnostic assay for detection of gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS ONE. 2014;9(4):e94064.CrossRefPubMedPubMedCentral
22.
Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, Meier FA. Evaluation of a microarray-based assay for rapid identification of gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol. 2013;51(4):1188–92.CrossRefPubMedPubMedCentral
23.
Jakovljev A, Bergh K. Development of a rapid and simplified protocol for direct bacterial identification from positive blood cultures by using matrix assisted laser desorption ionization time-of-flight mass spectrometry. BMC Microbiol. 2015;15(1):258.
Metadaten
Titel
Comparison of rapid hybridization-based pathogen identification and resistance evaluation in sepsis using the Verigene® device paired with “good old culture”
verfasst von
Michael Berktold
Wolfgang Mutschlechner
Dorothea Orth-Höller
Publikationsdatum
01.06.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 11-12/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1057-y

Weitere Artikel der Ausgabe 11-12/2017

A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria

  • Open Access
  • original article

Subacute cutaneous lupus erythematosus – paraneoplastic to gastric adenocarcinoma?

  • letter to the editors

Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients

  • original article

MedUni Wien Researcher of the Month Juni 2017

  • MUW researcher of the month

Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)

  • original article

Veranstaltungen

  • mitteilungen der gesellschaft der ärzte in wien